Dr. Qasim Chaudhry’s unique dual-training in Transplantation and Complex Liver Resection allows him to offer surgical options that are often unavailable in traditional general surgery or standard oncology practices. By applying transplant-level vascular techniques to oncology, he can successfully treat tumors previously deemed "unresectable."

Case Study: Liver Autotransplant & IVC Reconstruction

To illustrate the impact of this specialized skill set, Dr. Chaudhry recently treated a patient with a large tumor invading the Inferior Vena Cava (IVC).

• The Challenge: The tumor’s location required the removal of two-thirds of the liver and the complete resection of a segment of the major vein (IVC) returning blood to the heart.

• The Innovation: The 10-hour operation was performed under hypothermia (cooling the liver with preservation solution, a technique borrowed from transplantation) to protect the organ while the tumor was meticulously removed.

• The Result: The invaded vessel was successfully replaced with a synthetic graft (reimplantation of a vascular tube), restoring blood flow and allowing the patient to remain cancer-free with a functioning liver remnant.

When a liver tumor is too large to remove safely in a single operation, we must first ensure the remaining liver portion (Future Liver Remnant or FLR) is large enough to support the patient after surgery. We achieve this through two primary techniques:

The ALPPS Procedure (Associating Liver Partition and Portal Vein Ligation)

ALPPS is a cutting-edge, two-stage approach designed for rapid results.

• Stage 1: The future liver remnant is "cleaned" of any smaller lesions. The liver tissue is transected (divided), and the portal vein—the main blood supply to the diseased side—is surgically ligated.

• Stage 2: Because the liver is partitioned, it undergoes aggressive growth. After a short waiting period of only 10 days, the FLR typically achieves 80% hypertrophy (growth). At this point, the diseased part of the liver is removed.

• The Advantage: This is the fastest way to achieve a safe liver volume for patients with massive tumors.

Portal Vein Embolization (PVE)

PVE is a less invasive, non-surgical alternative to trigger liver growth.

• The Process: An interventional radiologist blocks the blood flow to the diseased portion of the liver using specialized beads or coils.

• The Timeline: While effective, PVE is a much slower process, often taking 8 weeks or more to achieve an adequate liver size before the tumor can be removed.

While liver transplantation is most commonly performed to treat liver failure secondary to cirrhosis, approximately 30% of transplants are now performed for the treatment of specific malignancies. For these patients, a transplant offers the best chance at long-term survival by removing both the tumor and the diseased liver environment that may be predisposed to future cancer growth.

Malignancies Treated with Transplantation

Transplantation is an increasingly effective option for several types of unresectable tumors:

• Primary Liver Tumors (Hepatocellular Carcinoma): Often treated within the "Milan Criteria" to ensure optimal long-term outcomes.

• Unresectable Klatskin Tumors (Hilar Cholangiocarcinoma): A specialized protocol involving chemotherapy and radiation followed by transplantation can offer a cure for tumors that cannot be removed with traditional surgery.

• Colorectal Cancer Metastasis: For specific patients whose cancer has spread only to the liver and cannot be removed via resection, transplantation is an emerging, life-saving frontier.

• Neuroendocrine Tumors: Transplantation can be considered for patients with slow-growing neuroendocrine metastases that are confined to the liver.

Microwave ablation utilizes electromagnetic waves to create a "microwave field," which causes polar molecules (primarily water) to vibrate and generate heat. This thermal energy leads to coagulative necrosis and immediate cellular death of the tumor tissue.

• Approach: Depending on the tumor's location, this can be performed percutaneously by an interventional radiologist using CT or ultrasound guidance, or via a laparoscopic/open surgical approach.

• Surgical Advantage: A laparoscopic approach is often preferred for tumors located near the diaphragm, gallbladder, or bowel. It allows the surgeon to use "pringle" maneuvers or physically displace adjacent organs to prevent collateral thermal injury.

• Indications: MWA is highly effective for primary liver tumors (HCC) and certain metastatic lesions (such as colorectal or neuroendocrine) that are typically under 3-5 cm in size.